Aveanna Healthcare Holdings, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the Aveanna Healthcare Holdings, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Aveanna Healthcare Holdings, Inc. has logged 202 insider filings. Market capitalisation: €2.9bn. The latest transaction was filed on 24 August 2026 (Cession). Among the most active insiders: VIGANO PAUL R. All data is accessible without an account.
€711,425
17 ops.
Buy Volume
Analyst consensus: bullish or bearish? Analysts rate Aveanna Healthcare Holdings, Inc. Buy (bullish), based on 10 analysts. Average price target: US$13.35.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,856 of 29,064 companies
FCF yld 4.1%
Earn yld 7.7%
EV/EBITDA 16.4x
ROE 199%
Gross mgn 33%
Net mgn 9.2%
Debt/EBITDA 5.6x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
All Executives202 Thresholds0 Prospectus0 Other0
Declarations 202 total
▼ 10% Owner · Executives · 20 Aug 2026
957,918 shares @ US$11.50 0.38% mcap 3.2% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:1
▼ 10% Owner · Executives · 20 Aug 2026
1,813,795 shares @ US$11.50 0.73% mcap 6.1% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:2
▼ Chief Administrative Officer · Executives · 20 Aug 2026
50,000 shares @ US$11.50 0.020% mcap 50.9% of flow Common Stock, par value $0.01 per share SEC:0001193125-26-363658:0
▼ Chief Executive Officer · Executives · 20 Aug 2026
90,000 shares @ US$11.50 0.036% mcap 42.6% of flow Common Stock, par value $0.01 per share SEC:0001193125-26-363661:0
▼ Director · Executives · 20 Aug 2026
180,000 shares @ US$11.50 0.072% mcap 75.1% of flow Common Stock, par value $0.01 per share SEC:0001193125-26-363665:0
▼ 10% Owner · Executives · 20 Aug 2026
10,112,125 shares @ US$11.50 4.04% mcap 34.3% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:0
▼ 10% Owner · Executives · 20 Aug 2026
1,813,795 shares @ US$11.50 0.73% mcap 6.1% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:2
▼ 10% Owner · Executives · 20 Aug 2026
1,426,034 shares @ US$11.50 0.57% mcap 4.8% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:3
▼ 10% Owner · Executives · 20 Aug 2026
190,130 shares @ US$11.50 0.076% mcap 0.6% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:4
▼ 10% Owner · Executives · 21 Aug 2026
2,250,000 shares @ US$11.50 0.90% mcap 7.6% of flow Common Stock, $0.01 par value SEC:0001193125-26-363860:5
▼ 10% Owner · Executives · 20 Aug 2026
10,112,125 shares @ US$11.50 4.04% mcap 34.3% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:0
▼ 10% Owner · Executives · 20 Aug 2026
957,918 shares @ US$11.50 0.38% mcap 3.2% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:1
▼ 10% Owner · Executives · 20 Aug 2026
1,426,034 shares @ US$11.50 0.57% mcap 4.8% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:3
▼ 10% Owner · Executives · 20 Aug 2026
190,130 shares @ US$11.50 0.076% mcap 0.6% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:4
▼ 10% Owner · Executives · 21 Aug 2026
2,250,000 shares @ US$11.50 0.90% mcap 7.6% of flow Common Stock, $0.01 par value SEC:0001193125-26-363868:5
▼ 10% Owner · Executives · 20 Aug 2026
10,112,125 shares @ US$11.50 4.04% mcap 37.9% of flow Common Stock, $0.01 par value SEC:0001193125-26-363869:0
▼ 10% Owner · Executives · 20 Aug 2026
957,918 shares @ US$11.50 0.38% mcap 3.6% of flow Common Stock, $0.01 par value SEC:0001193125-26-363869:1
▼ 10% Owner · Executives · 20 Aug 2026
1,426,034 shares @ US$11.50 0.57% mcap 5.3% of flow Common Stock, $0.01 par value SEC:0001193125-26-363869:2
▼ 10% Owner · Executives · 21 Aug 2026
2,250,000 shares @ US$11.50 0.90% mcap 8.4% of flow Common Stock, $0.01 par value SEC:0001193125-26-363869:3
▼ 10% Owner · Executives · 30 Jun 2026
2,419,035 shares Common Stock, $0.01 par value SEC:0001193125-26-293921:0
▼ 10% Owner · Executives · 30 Jun 2026
2,419,035 shares Common Stock, $0.01 par value SEC:0001193125-26-293930:0
▼ 10% Owner · Executives · 30 Jun 2026
525,844 shares Common Stock, $0.01 par value SEC:0001193125-26-293930:1
▼ 10% Owner · Executives · 30 Jun 2026
55,121 shares Common Stock, $0.01 par value SEC:0001193125-26-293930:2
▼ 10% Owner · Executives · 30 Jun 2026
2,419,035 shares Common Stock, $0.01 par value SEC:0001193125-26-293937:0
▼ 10% Owner · Executives · 30 Jun 2026
525,844 shares Common Stock, $0.01 par value SEC:0001193125-26-293937:1
25 of 202 declarations
Load more (177 remaining) 关于 Aveanna Healthcare Holdings, Inc. Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH) 是一家总部位于美国的家庭护理服务公司,专注于医疗复杂、高危患者群体。该公司总部位于美国佐治亚州亚特兰大,其股票在纳斯达克市场交易。Aveanna 建立了多元化的家庭护理平台,分为三个运营部门:私人护理服务 (PDS)、家庭健康与临终关怀 (HHH) 和医疗解决方案 (MS)。这种结构使公司能够满足广泛的护理需求,从持续的专业护理和儿科治疗到家庭健康、临终关怀和相关的医疗支持服务。
该业务的核心是私人护理,Aveanna 自称是美国最大的提供商。该公司为患有严重疾病的医疗脆弱儿童、青少年、成人和老年人提供服务,这些疾病需要在家庭中进行高度专业化、通常是持续的护理。典型的临床病例包括患有慢性呼吸衰竭、气管切开术和机械通气需求、脑瘫、囊性纤维化、先天性异常、发育迟缓和缺氧性脑损伤的患者。Aveanna 的服务组合还包括儿科治疗、认证家庭健康、临终关怀和支持服务,帮助家庭和转诊来源在比医院或机构成本更低的环境中协调护理。
从行业角度来看,Aveanna 在一个分散但至关重要的医疗保健市场中运营。其竞争地位更多地取决于临床能力、护理人员招聘和留用、与儿童医院和卫生系统的转诊关系以及高效提供复杂护理的能力,而不是消费者品牌。该公司强调,其模式有助于医院将一些医疗最敏感的患者送回家中,那里的护理通常成本更低,并且通常受到患者和家庭的青睐。这种定位在美国医疗保健系统中具有战略重要性,尤其是在支付方和政府合作伙伴继续寻求成本控制的情况下。
历史上,Aveanna 通过整合家庭护理资产和持续的运营转型实现了增长。公司目前的战略重点是提高利润率、标准化运营、加强其全国业务范围以及扩展其高危家庭护理平台。虽然该公司以美国为中心,但其业务范围是全国性的而非地方性的,使其能够为多个州的患者提供服务并参与广泛的报销渠道。
最近的发展是积极的。2025 年 11 月,Aveanna 公布了第三季度业绩,显示收入和调整后 EBITDA 同比强劲增长,管理层表示 Thrive Skilled Pediatric Care 的整合仍有望在年底前完成。2026 年 3 月,公司公布了 2025 年全年业绩,并披露了收购 Family First Homecare 的协议,加强了其在儿科家庭护理领域的扩张战略。对于投资者而言,AVAH 仍然是美国纳斯达克上市的医疗保健提供商,具有防御性需求特征,但执行风险仍然与人员配备、报销压力和收购整合相关。